Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/14/2014WO2014123793A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014123791A1 Nanoparticles containing a taxane and their use
08/14/2014WO2014123680A1 Antimicrobial methods using inhibitors of exchange proteins directly activated by camp (epac)
08/14/2014WO2014123612A1 Methods of treating melanoma
08/14/2014WO2014123500A1 Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid
08/14/2014WO2014123476A1 Improved treatment for adenoid cystic carcinoma
08/14/2014WO2014123364A1 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
08/14/2014WO2014123355A1 Orally administered celecoxib composition
08/14/2014WO2014123332A1 7h-pyrrolo[2,3-d]pyrimidine-4-thiol derivative useful as jak-3 inhibitor
08/14/2014WO2014123244A1 Solid dispersion comprising amorphous cilostazol
08/14/2014WO2014122670A1 Carbodithioates with spermicidal activity and process for preparation thereof
08/14/2014WO2014122646A1 Phosphorylcholine conjugates and uses thereof
08/14/2014WO2014122638A2 Thalidomide and thalidomide analogues for the stimulation in human/animals of stem cell factor to increase regenerative potential in aging conditions
08/14/2014WO2014122627A1 Basidiomycete-derived cream for treatment of skin diseases
08/14/2014WO2014122604A1 Anabolic ergogenic compositions based on polygonum fagopyrum
08/14/2014WO2014122586A1 Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
08/14/2014WO2014122585A1 A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
08/14/2014WO2014122580A1 Photocrosslinked hyaluronic acid derivatives, and the preparation process and use thereof
08/14/2014WO2014122537A2 Pharmaceutical compositions and methods of treating hepatitis c virus infection using a combination of hydroxychloroquine and ribavirin
08/14/2014WO2014122530A1 Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of use
08/14/2014WO2014122498A2 Cabazitaxel composition
08/14/2014WO2014122480A1 16- and 17- deuterated estrogen-3-sulfamates as estrogenic agents
08/14/2014WO2014122474A1 Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
08/14/2014WO2014122468A1 Combination therapy for the treatment of nosocomial pneumonia
08/14/2014WO2014122436A1 Topical pharmaceutical compositions comprising minoxidil
08/14/2014WO2014122303A1 Glucan synthase inhibitors
08/14/2014WO2014122298A1 Interleukin-4 inhibitors for the treamtent of neutropenia
08/14/2014WO2014122267A1 Substituted benzamides with activity towards ep4 receptors
08/14/2014WO2014122251A2 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by cd3-specific binding domains
08/14/2014WO2014122222A1 Hydroxamate derivatives bearing amide-lactams as potent hdac inhibitors and their uses as medicaments
08/14/2014WO2014122195A1 Pharmaceutical compositions incorporating low-dose drugs
08/14/2014WO2014122184A1 Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
08/14/2014WO2014122160A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/14/2014WO2014122067A1 New indanyloxydihydrobenzofuranylacetic acids
08/14/2014WO2014122024A1 Topical antifungal composition for treating onychomycosis
08/14/2014WO2014121901A1 Polymorphic forms
08/14/2014WO2014121885A1 Substituted quinoxaline derivatives and their use as positive allosteric modulators of mglur4
08/14/2014WO2014121883A1 Substituted acetylene derivatives and their use as positive allosteric modulators of mglur4
08/14/2014WO2014121634A1 Novel bacterial colony sensing regulator and medical use
08/14/2014WO2014121633A1 Derivative of homoserine lactone, and preparation method and use thereof
08/14/2014WO2014121418A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121417A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121416A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
08/14/2014WO2014121378A1 Conductive biomaterial for enhancement of conduction in vitro and in vivo
08/14/2014WO2014121343A1 Methods of treating microbial infections, including mastitis
08/14/2014WO2014121342A1 Methods of treating topical microbial infections
08/14/2014WO2014104989A8 Pharmaceutical compositions comprising aripiprazole
08/14/2014WO2014104906A3 Composition with increased bioavailability of orally administrated embryo-peptides and process for its obtainment
08/14/2014WO2014101295A3 Isoxazole derivative that inhibits activity of janus kinases (jaks)
08/14/2014WO2014100719A3 Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
08/14/2014WO2014100636A3 Methods of treating atherosclerosis or myeloproliferative neoplasms by administering a lyn kinase activator
08/14/2014WO2014097151A3 Autotaxin inhibitors
08/14/2014WO2014096418A3 Micrornas as therapeutics and biomarkers for epilepsy
08/14/2014WO2014096300A3 Antibacterial compounds
08/14/2014WO2014093305A3 Micrornas and uses thereof
08/14/2014WO2014090396A3 Use of maleimide derivatives for preventing and treating cancer
08/14/2014WO2014086480A8 Lignan compositions
08/14/2014WO2014066848A9 Super-enhancers and methods of use thereof
08/14/2014WO2014066659A9 Heteroaryl inhibitors of pde4
08/14/2014WO2013185112A8 Pharmaceutical compositions for the treatment of cftr -mediated disorders
08/14/2014WO2013045098A3 Use of propanol and propenol derivatives as antioxidants
08/14/2014WO2009070485A8 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES
08/14/2014US20140228812 Method for reducing tumors and transforming cancer cells
08/14/2014US20140228744 Appliances and compositions for oral use and methods for treating the oral mucosa, lips, and perioral regions
08/14/2014US20140228528 Polyguanidine silicate and use thereof
08/14/2014US20140228451 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/14/2014US20140228447 Agent for increasing testosterone level
08/14/2014US20140228444 Otic composition for companion animals
08/14/2014US20140228440 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
08/14/2014US20140228438 Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
08/14/2014US20140228437 Pharmaceutical composition
08/14/2014US20140228436 Organ protection solution and its method of use
08/14/2014US20140228435 Composition and method of synthesizing a biomolecule and its therapeutics applications
08/14/2014US20140228434 Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
08/14/2014US20140228433 3-methanesulfonylpropionitrile for treating inflammation and pain
08/14/2014US20140228432 Compositions
08/14/2014US20140228431 Method of treating constipation
08/14/2014US20140228428 Cynara scolymus extracts for the treatment of dyslipidaemia
08/14/2014US20140228427 Pharmaceutical composition containing wogonin as an active ingredient for preventing or treating asthma
08/14/2014US20140228425 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
08/14/2014US20140228423 Biomarkers and therapy for cancer
08/14/2014US20140228421 Methods For Inhibiting Native And Promiscuous Uptake Of Monoamine Neurotransmitters
08/14/2014US20140228420 Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
08/14/2014US20140228418 Combination therapy of hsp90 inhibitory compounds with mek inhibitors
08/14/2014US20140228417 Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
08/14/2014US20140228415 Substituted bisphenyl butanoic acid derivatives as NEP inhibitors with improved in vivo Efficacy
08/14/2014US20140228412 Apoptosis signal-regulating kinase inhibitor
08/14/2014US20140228411 Apoptosis signal-regulating kinase inhibitor
08/14/2014US20140228410 P38map kinase inhibitors
08/14/2014US20140228403 Compositions and methods for treating diseases of the nail
08/14/2014US20140228402 Combinations Comprising a S1P receptor modulator
08/14/2014US20140228401 Method for Treating Osteoporosis
08/14/2014US20140228398 COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
08/14/2014US20140228397 Propellant-free aerosol formulation for inhalation
08/14/2014US20140228396 Triazolopyridyl compounds as aldosterone synthase inhibitors
08/14/2014US20140228394 Inhibitors of cyp 17
08/14/2014US20140228391 Anise Flavored Medication
08/14/2014US20140228390 Pharmaceutical Formulation Containing Gelling Agent
08/14/2014US20140228389 Dry powder compound formulations and uses thereof
08/14/2014US20140228388 Phenyl-Guanidine Derivatives
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 7860